Erroneous formulation of delayed-release omeprazole capsules: alert for importing countries

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

PREVACID (lansoprazole) Delayed-Release Capsules PREVACID SoluTab (lansoprazole) Delayed-Release Orally Disintegrating Tablets For oral administration

-----------------------------DRUG INTERACTIONS--------------------------­ • Atazanavir: Do not co-administer with atazanavir. (7.1) • Drugs with pH-Dependent Absorption: May interfere with the absorption of drugs where gastric pH is important for bioavailability. (7.1) • Warfarin: Concomitant warfarin use may require monitoring for increases in INR and prothrombin time. (7.2) • Tacrolimus: Conc...

متن کامل

NEXIUM (esomeprazole magnesium) DELAYED-RELEASE CAPSULES NEXIUM (esomeprazole magnesium) FOR DELAYED-RELEASE ORAL SUSPENSION

_____________________________________________________ HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NEXIUM safely and effectively. See full prescribing information for NEXIUM. NEXIUM (esomeprazole magnesium) DELAYED-RELEASE CAPSULES NEXIUM (esomeprazole magnesium) FOR DELAYED-RELEASE ORAL SUSPENSION INITIAL US APPROVAL: 1989 (omeprazole)...

متن کامل

PREVACID (lansoprazole) Delayed-Release Capsules PREVACID (lansoprazole) For Delayed-Release Oral Suspension PREVACID SoluTab (lansoprazole) Delayed-Release Orally Disintegrating Tablets For oral administration

Dual Therapy: PREVACID Amoxicillin 30 mg 1 gram Three times daily for 14 days Benign Gastric Ulcer Short-Term Treatment (1.4) 30 mg Once daily up to 8 wks NSAID-associated Gastric Ulcer (1.6) Healing Risk Reduction 30 mg 15 mg Once daily for 8 wks Once daily up to 12 wks GERD (1.7) Short-Term Treatment of Symptomatic GERD 15 mg Once daily up to 8 wks Short-Term Treatment of EE 30 mg Once daily ...

متن کامل

Formulation and evaluation of rabeprazole sodium delayed release tablets

The main purpose of this work is to develop delayed release stable tablet formulation of Rabeprozole sodium by direct compression and wet granulation method and enteric coating of tablets. All enteric coated tablets are delayed release tablets but all delayed release tablets are not enteric coated tablets. The present work aims to avoid degradation of drug in acidic environment of stomach. Pref...

متن کامل

Development and validation of dissolution testings in acidic media for rabeprazole sodium delayed-release capsules

Rabeprazole sodium (RAB) dissolved in acidic media is accompanied by its degradation in the course of dissolution testing. To develop and establish the accumulative release profiles of ACIPHEX(®) Sprinkle (RAB) delayed-release capsules (ACIPHEX(®) Sprinkle) in acidic media using USP apparatus 2 (paddle apparatus) as a dissolution tester, the issues of determination of accumulative release amoun...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: BMC Pharmacology and Toxicology

سال: 2017

ISSN: 2050-6511

DOI: 10.1186/s40360-017-0138-5